CN105596388A - Lysimachia capillipes oral solution formula and preparation technology - Google Patents
Lysimachia capillipes oral solution formula and preparation technology Download PDFInfo
- Publication number
- CN105596388A CN105596388A CN201610084757.2A CN201610084757A CN105596388A CN 105596388 A CN105596388 A CN 105596388A CN 201610084757 A CN201610084757 A CN 201610084757A CN 105596388 A CN105596388 A CN 105596388A
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- thin
- vanilla
- stem
- herba lysimachiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 238000009472 formulation Methods 0.000 title description 4
- 241000941637 Lysimachia capillipes Species 0.000 title 1
- 229940100688 oral solution Drugs 0.000 title 1
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 230000001954 sterilising effect Effects 0.000 claims abstract 2
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims 3
- 239000012895 dilution Substances 0.000 claims 3
- 238000004945 emulsification Methods 0.000 claims 1
- 238000005057 refrigeration Methods 0.000 claims 1
- 235000009499 Vanilla fragrans Nutrition 0.000 abstract description 17
- 235000012036 Vanilla tahitensis Nutrition 0.000 abstract description 17
- 244000263375 Vanilla tahitensis Species 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 238000007689 inspection Methods 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 5
- 229930182490 saponin Natural products 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 235000017709 saponins Nutrition 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000208476 Primulaceae Species 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- BMWPBKOFJSHJAW-UHFFFAOYSA-N Saponin B Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(CO)C(O)C(OC7OC(CO)C(O)C(O)C7O)C6=O)C(C)(C)C5CCC34C)C2C1)C(=O)O BMWPBKOFJSHJAW-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical group OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002700 inhibitory effect on cancer Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/17—Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种细梗香草口服液配方及制备工艺。其特征在于按以下工序进行：(1)？细梗香草提取液制备；(2)？按100倍稀释并矫味；(3)制取口服液：将稀释矫味后的细梗香草提取液→灌装→封盖→杀菌→包装→检验→成品。该工艺制取细梗香草口服液不仅具有提神醒脑的保健功效，而且具有防癌抗癌的疗效。The invention relates to a formula and a preparation process of a thin-stem vanilla oral liquid. It is characterized in that it is carried out according to the following procedures: (1)? Preparation of thin-stem vanilla extract; (2)? Diluted by 100 times and flavored; (3) Preparation of oral liquid: dilute and flavored herb extract → filling → capping → sterilization → packaging → inspection → finished product. The thin stem vanilla oral liquid prepared by the process not only has the health care effect of refreshing the mind, but also has the curative effect of preventing and fighting cancer.
Description
技术领域 technical field
本发明涉及中药领域，特别涉及一种细梗香草口服液配方及制备工艺，以及由该工艺制备的细梗香草口服液。 The invention relates to the field of traditional Chinese medicines, in particular to a formula and a preparation process of the herb oral liquid, and the herb oral liquid prepared by the process.
背景技术 Background technique
口服液是一种大众保健品，服用口服液保健符合中国传统医学之治未病的理念，既有提神醒脑作用又有防治癌症和心血管病作用的口服液有很大的市场需求。细梗香草又名细梗香、满山香、排草、香草等，报春花科、珍珠菜族，其茎叶含芳香油。细梗香草精油经上海应用技术学院朱建才用气质联用色谱法分析，获得28种化合物，其中包括大茴香脑、咖啡碱等大量芳香物质，这些物质具有提神醒脑作用。徐燕等《细梗香草总皂苷的抗肿瘤活性研究》称，细梗香草的皂苷类成分对癌症肿瘤细胞有非常强的抑制作用。浙江大学田景奎等主持完成的浙江省科技计划项目“特色药材细梗香草抗肿瘤、治疗冠心病中药五类新药研究”称细梗香草具有抗肿瘤、治疗冠心病的作用。该成果认为，细梗香草单体皂苷具有抗肿瘤作用，其中皂苷B有非常强的抑制A2780卵巢癌细胞的作用，对PC3前列腺癌、SKov3卵巢癌、BGC823胃癌细胞等株的增殖具有显著的抑制作用，对A549肺癌细胞、MCF7乳腺癌细胞等8种细胞株的增殖具有较显著的抑制作用。 Oral liquid is a kind of public health care product. Taking oral liquid for health care is in line with the concept of traditional Chinese medicine to prevent diseases. There is a great market demand for oral liquid that not only refreshes the mind but also prevents cancer and cardiovascular diseases. Thin-stalked vanilla is also known as fine-stemmed incense, manshanxiang, paicao, vanilla, etc., and belongs to Primulaceae and Pearl Vegetable family. Its stems and leaves contain aromatic oil. The thin-stem vanilla essential oil was analyzed by Zhu Jiancai of Shanghai Institute of Applied Technology by GC-MS chromatography, and 28 compounds were obtained, including a large number of aromatic substances such as anethole and caffeine, which have a refreshing effect. Xu Yan et al. "Study on the Antitumor Activity of Total Saponins of Herb Vanilla" stated that the saponins of Herb Herb have a very strong inhibitory effect on cancer tumor cells. Zhejiang University Tian Jingkui and others presided over the Zhejiang Provincial Science and Technology Plan Project "Research on Five New Drugs of Traditional Chinese Medicine Herbs with Herbs and Herbs for Anti-tumor and Treatment of Coronary Heart Disease". According to the results, the saponins of the vanilloid saponins have anti-tumor effects, among which saponin B has a very strong inhibitory effect on A2780 ovarian cancer cells, and has a significant inhibitory effect on the proliferation of PC3 prostate cancer, SKov3 ovarian cancer, BGC823 gastric cancer cell lines, etc. It has a significant inhibitory effect on the proliferation of 8 cell lines including A549 lung cancer cells and MCF7 breast cancer cells.
细梗香草有效成分已作为抗肿瘤药物研制开发，其特点是提取了细梗香草中的皂苷类物质。但是，细梗香草用于医疗时病没有注意医用细梗香草中大量的其他有益物质。分析认为，细梗香草成分中没有不宜食用的成分，在民间，细梗香草产地长期以来用做窨茶，提供了细梗香草成分整体食用的实证。但是，目前并没有在细梗香草口服液问世。 The active ingredient of Herb Herb has been researched and developed as an anti-tumor drug, and its characteristic is that the saponins in Herb Herb are extracted. However, when the herb is used for medical treatment, there is no attention to a large number of other beneficial substances in the herb. According to the analysis, there are no inedible ingredients in the herb ingredients. In the folks, the origin of the herb has been used as a scented tea for a long time, which provides evidence that the herb ingredients can be eaten as a whole. But, do not come out in thin stem vanilla oral liquid at present.
发明内容 Contents of the invention
本发明的目的是提供一种细梗香草口服液配方和制备工艺，以及由该工艺制备的细梗香草口服液，通过采用先进高效的制备工艺进行细梗香草有效成分的萃取，提高药草利用率，并改善成品的稳定性以及口感。 The purpose of the present invention is to provide a formula and preparation process of Herbal Herbs Oral Liquid, and Herbs Herbs Oral Liquid prepared by the process, by adopting an advanced and efficient preparation process to extract the active ingredients of Herbs Herbs, so as to improve the utilization rate of herbs , and improve the stability and taste of the finished product.
本发明所述一种细梗香草口服液的制备工艺，其特征在于步骤如下：（1）细梗香草杀青、摄氏60度烘干、粉碎至60-80目，超临界二氧化碳法获得细梗香草提取液，过滤。（2）按100倍比例加蒸馏水稀释，再加入占口服液总重量3-5%的甜味剂。（3）将经过稀释矫味的口服液搅拌、高温杀菌，冷藏8-12h，过滤，装于10ml瓶中封口。 The preparation process of a thin-stem vanilla oral liquid according to the present invention is characterized in that the steps are as follows: (1) the thin-stem vanilla is greened, dried at 60 degrees Celsius, crushed to 60-80 mesh, and the thin-stem vanilla is obtained by supercritical carbon dioxide method Extract, filtered. (2) Dilute with distilled water at a ratio of 100 times, and then add a sweetener accounting for 3-5% of the total weight of the oral liquid. (3) Stir the diluted and flavored oral liquid, sterilize at high temperature, refrigerate for 8-12 hours, filter, put it in a 10ml bottle and seal it.
本发明所述一种细梗香草口服液配方和制备工艺，其特征在于：一种细梗香草口服液配方是细梗香草。 The formula and preparation process of the thin-stem vanilla oral liquid according to the present invention is characterized in that: the thin-stem vanilla oral liquid formula is the thin-stem vanilla.
本发明所述一种细梗香草口服液配方和制备工艺，其特征在于：甜味剂为阿斯巴甜或三氯蔗糖，芳香剂为细梗香草自有。 The formula and preparation process of the thin-stem vanilla oral liquid according to the present invention is characterized in that: the sweetener is aspartame or sucralose, and the flavoring agent is the self-contained thin-stem vanilla.
具体实施方式 detailed description
下面结合具体实施方式和对比实验来对本发明作进一步的说明，但是下文中的具体实施方法不应当被理解为对本发明的限制。本领域普通技术人员能够在本发明基础上显而易见地作出的各种改变和变化，应该均在本发明的范围之内。 The present invention will be further described below in conjunction with specific embodiments and comparative experiments, but the following specific implementation methods should not be construed as limiting the present invention. Various changes and changes that can be obviously made by those skilled in the art on the basis of the present invention should all fall within the scope of the present invention.
实施实例：（1）细梗香草鲜草100kg，杀青、摄氏60度烘干，获10kg细梗香草干叶。（2）细梗香草干10kg粉碎至60目，超临界二氧化碳萃取，按7ml/kg的提取液量计算，获70ml细梗香草提取液，过滤备用。（3）将70ml细梗香草提取液与7000ml蒸馏水混合，加蔗糖350g。（4）搅拌、高温杀菌，冷藏8-12h，过滤，装于10ml瓶中封口。 Implementation example: (1) 100kg of fresh herb of thin-stalked herb, de-enzyming and drying at 60 degrees Celsius, to obtain 10kg of dried herb of thin-stemmed herb. (2) 10kg of dried fine-stemmed herb was crushed to 60 mesh, extracted with supercritical carbon dioxide, calculated according to the extraction volume of 7ml/kg, and 70ml of fine-stemmed herb extract was obtained, filtered for later use. (3) Mix 70ml of thin-stem vanilla extract with 7000ml of distilled water, add 350g of sucrose. (4) Stir, sterilize at high temperature, refrigerate for 8-12 hours, filter, put in 10ml bottles and seal.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610084757.2A CN105596388A (en) | 2016-02-15 | 2016-02-15 | Lysimachia capillipes oral solution formula and preparation technology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610084757.2A CN105596388A (en) | 2016-02-15 | 2016-02-15 | Lysimachia capillipes oral solution formula and preparation technology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105596388A true CN105596388A (en) | 2016-05-25 |
Family
ID=55977123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610084757.2A Pending CN105596388A (en) | 2016-02-15 | 2016-02-15 | Lysimachia capillipes oral solution formula and preparation technology |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105596388A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300550A (en) * | 2022-08-24 | 2022-11-08 | 捷通国际有限公司 | Compositions and methods for inhibiting xanthine oxidase |
| CN116649448A (en) * | 2023-07-24 | 2023-08-29 | 上海纳米技术及应用国家工程研究中心有限公司 | A kind of preparation method and product thereof containing thin-stem vanilla tea drink |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101507740A (en) * | 2009-03-19 | 2009-08-19 | 浙江大学 | Lysimachia capillipes Hemsl. total saponin extract preparation method using macroporous resin and use thereof |
| CN102180938A (en) * | 2011-03-30 | 2011-09-14 | 浙江大学 | Method for preparing capilliposide |
-
2016
- 2016-02-15 CN CN201610084757.2A patent/CN105596388A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101507740A (en) * | 2009-03-19 | 2009-08-19 | 浙江大学 | Lysimachia capillipes Hemsl. total saponin extract preparation method using macroporous resin and use thereof |
| CN102180938A (en) * | 2011-03-30 | 2011-09-14 | 浙江大学 | Method for preparing capilliposide |
Non-Patent Citations (1)
| Title |
|---|
| 田景奎等: "细梗香草化学成分的研究", 《中国药学杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300550A (en) * | 2022-08-24 | 2022-11-08 | 捷通国际有限公司 | Compositions and methods for inhibiting xanthine oxidase |
| CN116649448A (en) * | 2023-07-24 | 2023-08-29 | 上海纳米技术及应用国家工程研究中心有限公司 | A kind of preparation method and product thereof containing thin-stem vanilla tea drink |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102972604A (en) | Honeysuckle flower herb tea composite and primary pulp preparation thereof | |
| CN105451577B (en) | Food, beverage composition and medical component containing fermentation east cactus and the preparation method for east cactus of fermenting | |
| CN104083476A (en) | Application of rose extract in preparing anti-depression medicaments | |
| CN105596388A (en) | Lysimachia capillipes oral solution formula and preparation technology | |
| CN104531497A (en) | Immunity enhancing edible vinegar and preparation method thereof | |
| KR20170140611A (en) | Functioanl tea with anticancer activity and manufacturing method thefeof | |
| JP2013035786A (en) | Autonomic nerve regulator | |
| CN106983787A (en) | It is a kind of to have by composition of stasis of blood function and preparation method thereof | |
| KR20130074121A (en) | Ginseng prosapogenin high concentration containing sanchi ginseng preparation using sonication and process for thereof | |
| CN105596699A (en) | Traditional Chinese medicine composition for clearing lung and suppressing coughing and preparation method thereof | |
| JP2016047859A (en) | Basal metabolic enhancer | |
| CN100378089C (en) | Method for extracting total flavonoids from stems and leaves of Scutellaria baicalensis | |
| KR101416673B1 (en) | Ginseng prosapogenin high concentration containing ginseng flower preparation using sonication and process for thereof | |
| CN103564109B (en) | Kudzuvine root-containing traditional Chinese medicinal health-care composition | |
| CN103169072A (en) | Ginseng composition, and preparation method and use thereof | |
| CN103157069B (en) | Miao medicament for treating cholecystitis | |
| KR101416669B1 (en) | Ginseng prosapogenin high concentration containing ginseng berry preparation using sonication and process for thereof | |
| CN106729422B (en) | Pulse-activating turmeric powder traditional Chinese medicine composition for assisting tumor radiotherapy and application thereof | |
| CN102885367B (en) | Boat-fruited sterculia seed beverage with throat protecting effect and preparation method thereof | |
| KR101381507B1 (en) | A Red ginseng using microwave and process for thereof | |
| CN105455120A (en) | Golden camellia tea assisted blood sugar lowering capsule | |
| CN104666779B (en) | A kind of medicine for treating non-small cell lung cancer and preparation method thereof | |
| CN105532993A (en) | Thin-stalk vanilla herbal tea and preparation method thereof | |
| CN103316197A (en) | Preparation method of allium chinensis saponins extract removing nitrite | |
| CN109771631A (en) | A kind of wrinkled giant hyssop ginger jujube composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160525 |
|
| WD01 | Invention patent application deemed withdrawn after publication |